Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 4, no: 5 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4H8X7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.437 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.432 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.330 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.593 |
DEG_SPOP_SBC_1 | 54 | 58 | PF00917 | 0.239 |
DOC_MAPK_MEF2A_6 | 116 | 124 | PF00069 | 0.277 |
DOC_MAPK_RevD_3 | 117 | 133 | PF00069 | 0.340 |
DOC_PP1_RVXF_1 | 108 | 114 | PF00149 | 0.228 |
DOC_PP4_FxxP_1 | 112 | 115 | PF00568 | 0.224 |
DOC_USP7_MATH_1 | 54 | 58 | PF00917 | 0.294 |
DOC_USP7_UBL2_3 | 128 | 132 | PF12436 | 0.344 |
LIG_14-3-3_CanoR_1 | 53 | 63 | PF00244 | 0.248 |
LIG_APCC_ABBA_1 | 109 | 114 | PF00400 | 0.224 |
LIG_BRCT_BRCA1_1 | 55 | 59 | PF00533 | 0.289 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.291 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.298 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.412 |
LIG_LIR_Gen_1 | 56 | 66 | PF02991 | 0.253 |
LIG_LIR_Nem_3 | 56 | 62 | PF02991 | 0.289 |
LIG_PDZ_Class_1 | 139 | 144 | PF00595 | 0.344 |
LIG_PTB_Apo_2 | 31 | 38 | PF02174 | 0.341 |
LIG_PTB_Phospho_1 | 31 | 37 | PF10480 | 0.341 |
LIG_SH2_SRC | 7 | 10 | PF00017 | 0.203 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 37 | 40 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.284 |
LIG_Sin3_3 | 18 | 25 | PF02671 | 0.211 |
LIG_SUMO_SIM_par_1 | 118 | 123 | PF11976 | 0.311 |
LIG_Vh1_VBS_1 | 1 | 19 | PF01044 | 0.389 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.264 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.661 |
MOD_GlcNHglycan | 141 | 144 | PF01048 | 0.619 |
MOD_GSK3_1 | 135 | 142 | PF00069 | 0.414 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.238 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.360 |
MOD_N-GLC_1 | 105 | 110 | PF02516 | 0.531 |
MOD_N-GLC_1 | 33 | 38 | PF02516 | 0.421 |
MOD_N-GLC_1 | 48 | 53 | PF02516 | 0.614 |
MOD_N-GLC_2 | 95 | 97 | PF02516 | 0.469 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.651 |
MOD_NEK2_2 | 48 | 53 | PF00069 | 0.297 |
MOD_Plk_1 | 105 | 111 | PF00069 | 0.339 |
MOD_Plk_1 | 48 | 54 | PF00069 | 0.381 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.238 |
MOD_Plk_2-3 | 118 | 124 | PF00069 | 0.322 |
MOD_Plk_4 | 135 | 141 | PF00069 | 0.439 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.376 |
MOD_Plk_4 | 97 | 103 | PF00069 | 0.315 |
MOD_SUMO_for_1 | 127 | 130 | PF00179 | 0.234 |
MOD_SUMO_rev_2 | 75 | 83 | PF00179 | 0.348 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NT01 | Trypanosomatidae | 40% | 100% |
A0A3S5IS80 | Trypanosoma rangeli | 38% | 100% |
A0A3S7WUB5 | Leishmania donovani | 57% | 100% |
A4HXA1 | Leishmania infantum | 57% | 100% |
C9ZTX4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AR03 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 100% |
Q4QEG0 | Leishmania major | 53% | 100% |
V5B7F7 | Trypanosoma cruzi | 37% | 100% |